Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

11-OH-CBN11-Hydroxycannabinol

Active cannabinol metabolite, CB1 agonist and weak CB2 antagonist in vitro.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₁H₂₆O₃

CAS 30432-08-7

Family
Metabolite
Molar mass
326.43 g/mol

Updated on

In plain terms

11-OH-CBN is the form cannabinol takes once the body has transformed it. In the laboratory, it binds CB1 and CB2 receptors much better than cannabinol. It is not sold and remains a research molecule.

Receptors and activity

Target network

CB1AgonistKi = 38 nM · ratbinding, transfected COS-7 cells; adenylyl cyclase EC50 58.1 nM
  • Activates
  • Blocks or inhibits

The lower the cited value, the closer the target sits to 11-OH-CBN: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of 11-OH-CBN.

Brain, side view
Body, front view
Blood

CB1CB1 found in 7 regions of the body

  1. Basal gangliadenseMost dense in basal ganglia outflow nuclei1
  2. CerebellumdenseVery dense in the cerebellum1
  3. HippocampusdenseVery high concentrations in the hippocampus2
  4. AmygdaladenseHigh concentrations in the amygdala2
  5. CortexpresentPresent throughout the neocortex2
  6. Adipose tissuepresentExpressed in adipose tissue3
  7. GutpresentColonic epithelium, smooth muscle and plexus4

Cited values

  1. CB1AgonistKi = 38 nM · rat57 out of 100

    Rhee et al. 1997, J Med Chem (new tab) · binding, transfected COS-7 cells; adenylyl cyclase EC50 58.1 nM

  2. CB2AntagonistKi = 26.6 nM · human60 out of 100

    Rhee et al. 1997, J Med Chem (new tab) · binding, transfected COS-7 cells; 20% inhibition of adenylyl cyclase at 10 µM

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

11-hydroxycannabinol is the C11-hydroxylated metabolite of cannabinol, described as its major metabolite by Yamamoto et al. (1987). Rhee et al. (1997) measured its affinity for rat CB1 (Ki 38.0 ± 7.2 nM) and human CB2 (Ki 26.6 ± 5.5 nM) expressed in COS-7 cells. It inhibits CB1-coupled adenylyl cyclase with an EC50 of 58.1 nM, but inhibits the CB2 pathway by only 20% at 10 µM: the authors call it a specific, though not potent, CB2 antagonist. In the same study, its dimethylheptyl homologue (11-OH-CBN-DMH) proved a very potent agonist at both receptors, with Ki values of 100 and 200 pM. The cannabinol it derives from is present in cannabis as a degradation product of THC; a single report of 11-hydroxycannabinol in seized marijuana (de A. Leite et al. 2018) has not been confirmed.

History

Source
11-OH-CBN forms in the body by hydroxylation of cannabinol (Yamamoto et al. 1987). Cannabinol itself is present in cannabis as a degradation product of THC. A single report of 11-hydroxycannabinol in seized marijuana samples (de A. Leite et al. 2018, identification by gas chromatography and mass spectrometry) has not been confirmed: its occurrence in the plant remains unestablished.

Metabolic pathway

No established plant pathway. In the body, the C11 methyl of cannabinol is hydroxylated to a primary alcohol, a reaction analogous to the one turning Δ9-THC into 11-OH-THC. The cytochrome P450 isoforms involved in humans were not found in the sources consulted.

Classification

Family, origin and source verification

Family

Metabolite

Chemistry

C5 side chain

Parent molecule

CBN

Active metabolite.

Natural trace reported

11-hydroxycannabinol is reported, by gas chromatography coupled to mass spectrometry, in an HPLC-purified fraction of marijuana samples seized in Brazil (de A. Leite et al. 2018). A single report, on seized and aged material, with no isolation confirmed by another team; unverified.

de A Leite J et al. Extraction and isolation of cannabinoids from marijuana seizures and characterization by 1H NMR allied to chemometric tools. Sci Justice 2018;58:355-365 (new tab)

Verification

Every fact on this entry was checked against its primary sources on 20 October 2026.

Wikipedia (English)

11-Hydroxycannabinol (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

Identifiers

Names

Common name
11-Hydroxycannabinol
IUPAC name
9-(hydroxymethyl)-6,6-dimethyl-3-pentylbenzo[c]chromen-1-ol
Other names
11-OH-CBN · 11-hydroxy-CBN

Identifiers

Formula
C₂₁H₂₆O₃
CAS
30432-08-7
PubChem CID
3082311(new tab)
InChIKey
YDKZOUNVEIGJPO-UHFFFAOYSA-N
SMILES
CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)CO)(C)C)O

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.